We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Brooklyn ImmunoTherapeutics Inc | AMEX:BTX | AMEX | Common Stock |
Price Change | % Change | Share Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 9.79 | 0 | 01:00:00 |
Delaware
|
001-11460
|
31-1103425
|
(State or Other Jurisdiction of Incorporation)
|
(Commission File Number)
|
(IRS Employer Identification No.)
|
10355 Science Center Drive, Suite 150
|
||
San Diego, California
|
92121 |
|
(Address of Principal Executive Offices)
|
(Zip Code)
|
☐ |
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
☐ |
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
☐ |
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
☐ |
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
Title of each class
|
Trading symbol
|
Name of each exchange on which registered
|
||
Common Stock, par value $0.005 per share
|
BTX
|
The Nasdaq Stock Market LLC
|
Emerging growth company ☐
|
Item 5.07
|
Submission of Matters to a Vote of Security Holders.
|
Director
|
Votes
For
|
Votes
Withheld
|
Broker
Non-Votes
|
|||
Charles Cherington
|
24,960,908
|
3,213,277
|
14,849,874
|
|||
Matthew Angel
|
26,060,381
|
2,113,804
|
14,849,874
|
|||
Nicholas J. Singer
|
26,037,962
|
2,136,223
|
14,849,874
|
|||
Gregory Fiore
|
25,923,220
|
2,250,965
|
14,849,874
|
|||
William Wexler
|
26,044,952
|
2,129,233
|
14,849,874
|
Votes
For
|
Votes
Against
|
Abstentions
|
Broker
Non-Votes
|
|||
23,660,694
|
4,462,421
|
51,070
|
14,849,874
|
Votes
For
|
Votes
Against
|
Abstentions
|
Broker
Non-Votes
|
|||
42,584,506
|
373,779
|
65,774
|
—
|
Votes
For
|
Votes
Against
|
Abstentions
|
Broker
Non-Votes
|
|||
40,383,795
|
2,603,310
|
36,954
|
—
|
Brooklyn ImmunoTherapeutics, Inc.
|
||
Dated: September 23, 2022
|
By:
|
/s/ Andrew Jackson
|
Chief Financial Officer
|
1 Year Brooklyn ImmunoTherapeut... Chart |
1 Month Brooklyn ImmunoTherapeut... Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions